Pancreatic Cancer Action Network launches campaign to increase disease awareness

NewsGuard 100/100 Score

Lisa Niemi Swayze joins the Pancreatic Cancer Action Network to launch "Be a Hero in the Fight Against Pancreatic Cancer: Know it. Fight it. End it." campaign to increase awareness of the deadly disease that claimed the life of her husband, actor Patrick Swayze, one year ago.

The campaign leads up to National Pancreatic Cancer Awareness Month in November and will consist of a series of videos and messages from Mrs. Swayze among others. Supporters are encouraged to visit www.knowitfightitendit.org to learn how they can take action and be a hero in the fight against pancreatic cancer, such as contacting their elected officials to encourage them to co-sponsor the Pancreatic Cancer Research and Education Act, and uploading videos stories about the heroes in their life.

"My husband Patrick not only touched the lives of millions with his work, but also with the strength and courage he displayed during his fight against pancreatic cancer; he was a hero around the world. While it is bittersweet to mark this day, it is imperative that people understand the severity of this disease and the urgent need for increased research funding," stated Lisa Niemi Swayze. "We must engage an army of heroes in the fight against pancreatic cancer so we can know it, fight it and end it."

The five year survival rate for pancreatic cancer is estimated at just 6 percent; it is the only cancer of the top ten cancer killers that has a survival rate still in the single digits. This dismal survival rate is due in large part to the lack of scientific progress and the limited federal funding for the disease. Currently, only 2 percent of the National Cancer Institute's (NCI) annual research budget is dedicated to pancreatic cancer. As a result, there are no early detection methods and few effective treatment options for patients faced with this disease.

"Through the Be a Hero campaign and the ongoing efforts of the Pancreatic Cancer Action Network, our goal is to attract more advocates for this disease," stated Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. "We need more heroes in this fight to ensure progress is made and to increase both private and federal funding for research; a major component of this effort is to call on Congress to pass the Pancreatic Cancer Research and Education Act."

The Pancreatic Cancer Research and Education Act will ensure scientific progress is made by providing the NCI with the tools and resources it needs to develop and implement a strategic plan for pancreatic cancer research so early detection methods and effective treatment options can be identified. The bill was introduced in the House as H.R. 745 by Representatives Anna Eshoo (D-CA) and Ginny Brown-Waite (R-FL) and in the Senate as S. 3320 by Sheldon Whitehouse (D-RI).

"During his nearly two year battle with pancreatic cancer, Patrick significantly increased the visibility of the disease by speaking publicly about the challenges he faced and the need to increase federal funding for cancer research," added Fleshman. "We are thrilled to have Lisa carry on his legacy by joining the Pancreatic Cancer Action Network as a spokesperson, and hero, for this campaign and for our cause."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions